Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.

Imagen de Luis Montaner
PDF versionPDF version
TítuloPresence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
Publication TypeJournal Article
Year of Publication2003
AutoresPapasavvas, E, Sandberg, JK, Rutstein, R, Moore, EC, Mackiewicz, A, Thiel, B, Pistilli, M, June, RR, Jordan, KA, Gross, R, Maino, VC, Nixon, DF, Montaner, LJ
JournalJ Infect Dis
Volume188
Issue6
Pagination873-82
Date Published2003 Sep 15
ISSN0022-1899
Palabras claveAdolescent, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Child, HIV Infections, HIV-1, Humans, Immunologic Memory, Immunophenotyping, Lymphocyte Activation, RNA, Viral, Viral Load
Abstract

The present study assessed antiviral T cell immune responses in 48 human immunodeficiency virus (HIV)-infected children with a stable or decreasing CD4(+) T cell counts and different levels of viral control, in the presence or absence of antiretroviral therapy. Children with full (<40 copies/mL) or partial (<50,000 copies/mL) virus suppression and with a history of stable CD4(+) T cell counts had significantly increased levels of anti-HIV CD4(+) T cell lymphoproliferative responses, lower levels of CD38(+), and higher CD8(+)/CD28(+) T cell percentage, compared with those in treated children with a lack of virus suppression (>50,000 copies/mL). Levels of anti-HIV CD8(+) T cell activity, although higher in treated children with a lack of virus suppression, were not significantly different between the groups. Although levels of anti-HIV CD4(+) and CD8(+) T cell responses were not associated, these levels of responses were associated with the percentage of specific T cell subsets. Overall, a history of stable CD4(+) T cell counts, as a result of therapy that imparted full or partial virus suppression, was associated with increased levels of anti-HIV CD4(+) T helper responses and decreased T cell activation.

DOI10.1086/377645
Alternate JournalJ. Infect. Dis.
PubMed ID12964119
Grant ListAI44595 / AI / NIAID NIH HHS / United States
AI48398 / AI / NIAID NIH HHS / United States
MH 01584 / MH / NIMH NIH HHS / United States